An exploratory, descriptive, prospective cohort study assessing immunogenicity of COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic diseases (AIIRDs)
Latest Information Update: 10 Jan 2022
At a glance
- Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 10 Jan 2022 New trial record